Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Bonomini

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Molecules (Basel, Switzerland)|September 25, 2019
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal DialysisMario Bonomini, Lorenzo Di Liberato, Victor Zammit, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Nephrotoxicity induced by chemotherapy]Roberto Di Vito, Vittorio Sirolli, Luigi Amoroso, et al.
BMC Nephrology|May 9, 2021
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report studyLuigi Vecchi, Mario Bonomini, Roberto Palumbo, et al.
Pharmacology & Therapeutics|September 17, 2008
Carnitine in metabolic disease: potential for pharmacological interventionArduino Arduini, Mario Bonomini, Vincenzo Savica, et al.
International Journal of Molecular Sciences|August 29, 2024
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease PatientsZeeba Saeed, Vittorio Sirolli, Mario Bonomini, et al.
Advanced Drug Delivery Reviews|September 1, 2009
Carnitine, mitochondrial function and therapyVictor A Zammit, Rona R Ramsay, Mario Bonomini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[L-carnitine in peritoneal dialysis]Amedeo Franco De Vecchi, Arduino Arduini, Lorenzo Di Liberato, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist]Danilo D'Ettorre, Lorenzo Di Liberato, Vittorio Sirolli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 9, 2017
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia]Mario Bonomini, Arduino Arduini, Vittorio Sirolli, et al.
International Journal of Molecular Sciences|July 16, 2020
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological ConsiderationsLuca Piscitani, Vittorio Sirolli, Lorenzo Di Liberato, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Molecules (Basel, Switzerland)|September 25, 2019
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal DialysisMario Bonomini, Lorenzo Di Liberato, Victor Zammit, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Nephrotoxicity induced by chemotherapy]Roberto Di Vito, Vittorio Sirolli, Luigi Amoroso, et al.
BMC Nephrology|May 9, 2021
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report studyLuigi Vecchi, Mario Bonomini, Roberto Palumbo, et al.
Pharmacology & Therapeutics|September 17, 2008
Carnitine in metabolic disease: potential for pharmacological interventionArduino Arduini, Mario Bonomini, Vincenzo Savica, et al.
International Journal of Molecular Sciences|August 29, 2024
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease PatientsZeeba Saeed, Vittorio Sirolli, Mario Bonomini, et al.
Advanced Drug Delivery Reviews|September 1, 2009
Carnitine, mitochondrial function and therapyVictor A Zammit, Rona R Ramsay, Mario Bonomini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 3, 2011
[L-carnitine in peritoneal dialysis]Amedeo Franco De Vecchi, Arduino Arduini, Lorenzo Di Liberato, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist]Danilo D'Ettorre, Lorenzo Di Liberato, Vittorio Sirolli, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 9, 2017
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia]Mario Bonomini, Arduino Arduini, Vittorio Sirolli, et al.
International Journal of Molecular Sciences|July 16, 2020
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological ConsiderationsLuca Piscitani, Vittorio Sirolli, Lorenzo Di Liberato, et al.
Pageof 12